On June 18th, Gelunhui reported that Sihuan Pharm (00460.HK) announced that on June 18, 2024, the trustee purchased a total of 5 million shares of the company's stock on the market for the share incentive plan, with an average cost of about HK$0.558 per share.
四环医药(00460.HK)：受托人根据股份奖励计划购买合共500万股
Sihuan Pharm (00460.HK): The trustee purchased a total of 5 million shares according to the share incentive plan.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.